Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Sell
20
PHVS Quote, Financials, Valuation and Earnings
Last price:
$11.80
Seasonality move
:
11.1%
Day range:
$11.66 - $12.19
52-week range:
$11.51 - $25.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.35x
Volume:
56.7K
Avg. volume:
41.2K
1-year change:
-46.21%
Market cap:
$653.9M
Revenue:
--
EPS (TTM):
-$2.82
PHVS Analysts' Consensus Rating
The 4 analysts providing 12-month price projections for Pharvaris NV shares anticipate an average target of $35.67, ranging from a low estimate of $13.71 to a high estimate of $55.13. This average target implies a growth of 197.27% compared to the current stock price of $12.00.
Consensus Price Target
$35.67
Highest Price Target
$55.13
Lowest Price Target
$13.71
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
PHVS Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
